Copyright
©The Author(s) 2024.
World J Nephrol. Mar 25, 2024; 13(1): 88972
Published online Mar 25, 2024. doi: 10.5527/wjn.v13.i1.88972
Published online Mar 25, 2024. doi: 10.5527/wjn.v13.i1.88972
Initial variables | Results, n = 10 |
Gender (female) | 3 (30) |
Age (yr) | 29.00 ± 15.87 |
Weight (kg) | 54.23 ± 27.17 |
Height (m) | 1.62 ± 0.08 |
Body mass index (kg/m2) | 20.11 ± 7.90 |
Diagnosis-biopsy time (months) | 60 (39-60) |
Hypertension | 5 (50) |
Use loop of Henle diuretics | 3 (30) |
Spironolactone use | 2 (20) |
Use of ACE inhibitors | 5 (50) |
Antiplatelet use | 2 (20) |
Warfarin use | 1 (10) |
Surgery prior to kidney biopsy | 5 (50) |
Serum creatinine (mg/dL) | 1.73 ± 2.10 |
Blood urea nitrogen (mg/dL) | 30.57 ± 29.32 |
Proteinuria (mg/24 h) | 4843 (4079-6490) |
Hemoglobin (g/L) | 15.33 ± 4.45 |
Hematocrit (%) | 48.07 ± 17.32 |
Platelets × 109/L | 288.00 ± 82.00 |
Hematuria | 0 (0) |
Variables prior to performing the renal biopsy | Results, n = 10 |
Serum creatinine (mg/dL) | 2.17 ± 1.88 |
Pre-biopsy BUN (mg/dL) | 37.25 ± 4.74 |
Proteinuria prior to biopsy (mg/24 h) | 6193.00 ± 6165.00 |
Hemoglobin (g/dL) | 14.10 ± 3.76 |
Hematocrit (%) | 43.90 ± 12.96 |
Hematuria | 2 (20%) |
Platelets × 109/L | 281.00 ± 78.15 |
Skin-kidney distance (cm) | 2.100 ± 0.264 |
Renal length (cm) | 9.160 ± 1.011 |
Renal width (cm) | 3.86 ± 0.64 |
Lobulated borders | 6 (60%) |
Ratio Cortex Medulla preserved | 2 (20%) |
Transverse biopsy technique | 10 (100%) |
Insufficient sample | 4 (40%) |
Number passes | 1 |
Glomeruli | 13.00 ± 6.55 |
Intersticial fibrosis (%) | 46.67 (45.00-50.00) |
Complications | 3 (30%) |
Gender | Age | Type of heart disease | Diagnosis | Glomeruli | Creatinine (mg/dL) | Proteinuria (g/g/24 h) | Renal measurements (cm) | Complications |
Male | 17 | Dextromorphism with common atrium, absence of right ventricular atrial septal defect | FSGS NOS | 14 | 2.89 | 1.70 | 8.0 × 3.6 | None |
Female | 23 | Acianogen VSD | FSGS NOS | 19 | 1.75 | 14.69 | 9.8 × 3.4 | None |
Male | 47 | Dextrocardia concordant atrioventricular and ventricular-arterial connection | FSGS NOS | 6 | 1.88 | 1.91 | 9.7 × 4.6 | None |
Female | 57 | ASD | IgA nephropathy | 18 | 1.41 | 3.23 | 8.7 × 4.2 | None |
Male | 38 | Persistent ductus arteriosus + Eisenmenger Syndrome | FSGS NOS | 25 | 1.02 | 4.09 | 10.1 × 5.3 | Haematuria |
Male | 33 | Pulmonary atresia | FSGS NOS | 6 | 8.25 | 10.89 | 9.4 × 4.3 | Perirenal hematoma |
Female | 20 | Infundibular VSD | GMN proliferative membrane immune complexes | 11 | 1.98 | 8.25 | 9.9 × 4.3 | None |
Male | 69 | Ebstein Anomaly | FSGS Perihiliar | 13 | 4.27 | 1.58 | 9.3 × 4.3 | None |
Male | 19 | Tetralogy of fallot | FSGS NOS | 6 | 3.24 | 5.18 | 8.4 × 4.2 | Perirenal hematoma |
Male | 41 | Tetralogy of fallot | FSGS NOS | 8 | 1.93 | 3.70 | 8.96 × 4.24 | None |
- Citation: Juarez-Villa JD, Zepeda-Quiroz I, Toledo-Ramírez S, Gomez-Johnson VH, Pérez-Allende F, Garibay-Vega BR, Rodríguez Castellanos FE, Moguel-González B, Garcia-Cruz E, Lopez-Gil S. Exploring kidney biopsy findings in congenital heart diseases: Insights beyond cyanotic nephropathy. World J Nephrol 2024; 13(1): 88972
- URL: https://www.wjgnet.com/2220-6124/full/v13/i1/88972.htm
- DOI: https://dx.doi.org/10.5527/wjn.v13.i1.88972